We only have this paper's title and publication details.
Read it at the sourcePilot study finds oral propranolol reduces epistaxis frequency in hereditary haemorrhagic telangiectasia, suggesting a potential treatment option.
No takes yet. Share an insight, caveat, or question.
Grigg et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: